|

Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City

RECRUITINGSponsored by Zhongshan People's Hospital, Guangdong, China
Actively Recruiting
SponsorZhongshan People's Hospital, Guangdong, China
Started2020-04-01
Est. completion2024-12-31
Eligibility
Age30 Years – 69 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04085900

Summary

All participants will be tested for EBV associated biomarkers, including EBNA1-IgA, VCA-IgA, BNLF2b total antibodies (P85-Ab) et al. For all male participants and P85-Ab positive female participants, EBV DNA in plasma will be tested. Screening positive participants will be followed up annually. All subjects will also be followed by record linkage to Cancer Register and Population Register.

Eligibility

Age: 30 Years – 69 YearsHealthy volunteers accepted
Inclusion Criteria:

* Subject residents in Zhongshan City or Wuzhou City
* Subject has no medical record of nasopharyngeal carcinoma
* ECOG 0-2
* Subject is able to comprehend, sign, and date the written informed consent document to participate in the study.
* Subject has psychical condition and well consciousness, and also accept and cooperate with the follow-up of this study.

Exclusion Criteria:

* Subject has heavy cardiovascular, liver or kidney disease.
* Subject has contraindications to nasopharyngeal fiberoptic endoscopy.

Conditions2

CancerNasopharyngeal Carcinoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.